Bharat Biotech submits Covaxin's Phase III trial data to DCGI: Govt sources

The Hyderabad-based COVID vaccine manufacturing company Bharat Biotech submitted data from the Phase III clinical trials of Covaxin to Drugs Controller General of India (DCGI) over the weekend, according to government sources. 

from IndiaTV India: Google News Feed https://ift.tt/3d3dcR1

Get Breaking news, Live news, and latest news from India and around the world on INDILIVENEWS.com, which are in the interest of nation and humanity. Like us on Facebook or Follow us on Twitter and Reddit for the latest news blog and live news update

Trending News

Loading...